Project 1: Molecular signatures of lethal and indolent prostate cancer
Project closed

Project 1: Supplement IPBS Supplement Project 1
Principal Investigator: Massimo Loda, MD (DFCI)

Project 2: Genetic and clinical characterization of the 8q24 prostate cancer risk locus
Principal Investigator: Matthew Freedman, MD (DFCI)

Project 2: Supplement IPBS Supplement Project 2
Principal Investigator: Massimo Loda, MD (DFCI)

Project 3: TMPRSS2:ERG and SPINK1 prostate cancer
Co-Principal Investigators: Lorelei Mucci, MPH ScD (BWH) and Massimo Loda, MD (DFCI)

Project 4: Modulating transcription factor targets via chemical genomics
Co-Principal Investigators: Todd Golub, MD (DFCI/Broad) and Mary Ellen Taplin, MD (DFCI)

Project 5: The androgen receptor in hormone refractory disease
Co-Principal Investigators: Myles Brown, MD (DFCI) and Steven Balk, MD, PhD (BIDMC)